retatrutide clinical trials weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Effects of once-weekly subcutaneous retatrutide

The main hormonal alterations found in PCOS include increased luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio, hyperandrogenism, and insulin resistance, with consequent compensatory hyperinsulinemia, occasionally independent of body weight [2, 8]

These medications have been shown to not only support weight loss but also help manage blood sugar levels, addressing two common struggles that often feel impossible to tackle simultaneously

References AL-Mhanna SB, Batrakoulis A, Wan Ghazali WS, et al

Whether your combination was prescribed by a physician or self-initiated, here is what you should be doing right now